These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38561673)

  • 1. Acetate ameliorates ovarian mitochondrial dysfunction in letrozole-induced polycystic ovarian syndrome rat model by improving mitofusin-2.
    Olaniyi KS; Areloegbe SE
    J Physiol Sci; 2024 Apr; 74(1):22. PubMed ID: 38561673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac energy depletion in a rat model of polycystic ovarian syndrome is reversed by acetate and associated with inhibitory effect of HDAC2/mTOR.
    Olaniyi KS; Areloegbe SE; Fiemotongha FE
    Eur J Pharmacol; 2024 Jan; 962():176243. PubMed ID: 38048978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Role of Acetate Against Depressive-Like Behaviour Associated with Letrozole-Induced PCOS Rat Model: Involvement of HDAC2 and DNA Methylation.
    Wolugbom JA; Areloegbe SE; Olaniyi KS
    Mol Neurobiol; 2023 Jan; 60(1):355-368. PubMed ID: 36269541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of PCSK9/NF-kB-dependent pathways by acetate ameliorates cardiac inflammation in a rat model of polycystic ovarian syndrome.
    Olaniyi KS; Areloegbe SE
    Life Sci; 2022 Jul; 300():120560. PubMed ID: 35452635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agaricus Subrufescens ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with Letrozole induced polycystic ovarian syndrome.
    Bukke SPN; Pathange BBR; Karumanchi SK; Marri J; Boyina R; Rachamsetty K; Manchikalapati B; Odoma S; Hussaini B
    J Ovarian Res; 2023 Nov; 16(1):221. PubMed ID: 37993900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetate attenuates hypothalamic pyroptosis in experimentally induced polycystic ovarian syndrome.
    Olaniyi KS; Agan SU; Areloegbe SE; Sabinari IW; Oniyide AA; Enye LA; Omoaghe AO; Adekeye AO; Adeoluwa OA
    BMC Res Notes; 2024 Sep; 17(1):260. PubMed ID: 39267194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short chain fatty acid, acetate restores ovarian function in experimentally induced PCOS rat model.
    Olaniyi KS; Bashir AM; Areloegbe SE; Sabinari IW; Akintayo CO; Oniyide AA; Aturamu A
    PLoS One; 2022; 17(7):e0272124. PubMed ID: 35881588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose spironolactone-mediated androgen-adiponectin modulation alleviates endocrine-metabolic disturbances in letrozole-induced PCOS.
    Olaniyi KS; Oniyide AA; Adeyanju OA; Ojulari LS; Omoaghe AO; Olaiya OE
    Toxicol Appl Pharmacol; 2021 Jan; 411():115381. PubMed ID: 33359182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetate circumvents impaired metabolic switch in skeletal muscle of letrozole-induced PCOS rat model by suppression of PDK4/NLRP3.
    Olaniyi KS; Areloegbe SE
    Nutrition; 2023 Mar; 107():111914. PubMed ID: 36521396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Potential of Methanol Extract of Drymaria cordata Willd. ex Schult (MEDC) on Letrozole-Induced Polycystic Ovary Syndrome Via Modulation of Apoptotic Markers, Sex Hormones and Antioxidant Status in Rat Model.
    Olowofolahan AO; Olanlokun JO; Olorunsogo OO
    Reprod Sci; 2024 Sep; 31(9):2849-2860. PubMed ID: 38773025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetate mitigates cardiac mitochondrial dysfunction in experimental model of polycystic ovarian syndrome by modulating GPCR41/43 and PROKR1.
    Areloegbe SE; Olaniyi KS
    Biochem Biophys Res Commun; 2023 Nov; 681():62-72. PubMed ID: 37757668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: Targeting mitochondrial approach (selenium in PCOS).
    Atef MM; Abd-Ellatif RN; Emam MN; Abo El Gheit RE; Amer AI; Hafez YM
    Arch Biochem Biophys; 2019 Aug; 671():245-254. PubMed ID: 31251923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Selenium Nanoparticles on Letrozole-Induced Polycystic Ovarian Syndrome in Female Wistar Rats.
    Butt MA; Shafique HM; Mustafa M; Moghul NB; Munir A; Shamas U; Tabassum S; Kiyani MM
    Biol Trace Elem Res; 2023 Nov; 201(11):5213-5229. PubMed ID: 36694071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diacerein ameliorates letrozole-induced polycystic ovarian syndrome in rats.
    Ibrahim YF; Alorabi M; Abdelzaher WY; Toni ND; Thabet K; Hegazy A; Bahaa HA; Batiha GE; Welson NN; Morsy MA; Venugopala KN; Abdel-Aziz AM
    Biomed Pharmacother; 2022 May; 149():112870. PubMed ID: 35367769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhamnocitrin Attenuates Ovarian Fibrosis in Rats with Letrozole-Induced Experimental Polycystic Ovary Syndrome.
    Zhou Y; Lan H; Dong Z; Li W; Qian B; Zeng Z; He W; Song JL
    Oxid Med Cell Longev; 2022; 2022():5558599. PubMed ID: 35663203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyrate alleviates renal inflammation and fibrosis in a rat model of polycystic ovarian syndrome by suppression of SDF-1.
    Bashir AM; Olaniyi KS
    BMC Pharmacol Toxicol; 2023 Oct; 24(1):48. PubMed ID: 37789355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of HIF-1α/BNIP3 mediated mitophagy in mitochondrial dysfunction of letrozole-induced PCOS rats.
    Wang F; Han J; Wang X; Liu Y; Zhang Z
    J Mol Histol; 2022 Oct; 53(5):833-842. PubMed ID: 35951252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity.
    Olaniyi KS; Areloegbe SE; Oyeleke MB
    Endocrine; 2022 Dec; 78(3):628-640. PubMed ID: 36114434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alleviation of adipose-hepatic glycolipid dysregulation by acetate in experimental PCOS model is associated with NF-κB/NLRP3 repression.
    Olaniyi K; Areloegbe S
    Can J Physiol Pharmacol; 2023 Dec; 101(12):630-641. PubMed ID: 37590975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.